Form 6-K China Nepstar Chain Drug For: Sep 02
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
China Nepstar Chain Drugstore (NPD) Reports Q2 EPS of RMB0.09
September 2, 2015 6:10 AM EDTChina Nepstar Chain Drugstore (NYSE: NPD) reported Q2 EPS of RMB0.09, versus (RMB0.08) reported last year. Revenue for the quarter came in at RMB775.08 million, versus RMB686.55 million reported last year.
For earnings history and earnings-related data on China Nepstar Chain Drugstore (NPD) click here.
... More